|
US6749853B1
(en)
|
1992-03-05 |
2004-06-15 |
Board Of Regents, The University Of Texas System |
Combined methods and compositions for coagulation and tumor treatment
|
|
US5965132A
(en)
*
|
1992-03-05 |
1999-10-12 |
Board Of Regents, The University Of Texas System |
Methods and compositions for targeting the vasculature of solid tumors
|
|
US6953668B1
(en)
|
1992-11-05 |
2005-10-11 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen
|
|
US7070782B1
(en)
|
1992-11-05 |
2006-07-04 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen
|
|
US7105159B1
(en)
|
1992-11-05 |
2006-09-12 |
Sloan-Kettering Institute For Cancer Research |
Antibodies to prostate-specific membrane antigen
|
|
US6569432B1
(en)
*
|
1995-02-24 |
2003-05-27 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen and uses thereof
|
|
EP0812356B1
(en)
|
1995-02-24 |
2006-02-08 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen and uses thereof
|
|
US20040253246A1
(en)
*
|
1996-02-23 |
2004-12-16 |
Israeli Ron S. |
Prostate-specific membrane antigen and uses thereof
|
|
US6962981B1
(en)
|
1996-03-25 |
2005-11-08 |
Medarex, Inc. |
Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
|
|
US7381407B1
(en)
*
|
1996-03-25 |
2008-06-03 |
Medarex, Inc. |
Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
|
|
US6150508A
(en)
*
|
1996-03-25 |
2000-11-21 |
Northwest Biotherapeutics, Inc. |
Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
|
|
US6136311A
(en)
*
|
1996-05-06 |
2000-10-24 |
Cornell Research Foundation, Inc. |
Treatment and diagnosis of cancer
|
|
US20060269532A1
(en)
*
|
1997-02-25 |
2006-11-30 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
|
US20060024301A1
(en)
*
|
1997-02-25 |
2006-02-02 |
Corixa Corporation |
Prostate-specific polypeptides and fusion polypeptides thereof
|
|
US6759515B1
(en)
*
|
1997-02-25 |
2004-07-06 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
|
US6207805B1
(en)
*
|
1997-07-18 |
2001-03-27 |
University Of Iowa Research Foundation |
Prostate cell surface antigen-specific antibodies
|
|
US6232287B1
(en)
*
|
1998-03-13 |
2001-05-15 |
The Burnham Institute |
Molecules that home to various selected organs or tissues
|
|
US6200765B1
(en)
|
1998-05-04 |
2001-03-13 |
Pacific Northwest Cancer Foundation |
Non-invasive methods to detect prostate cancer
|
|
FR2791573B1
(fr)
*
|
1999-03-30 |
2003-04-11 |
Pf Medicament |
Utilisation d'un extrait de serenoa repens pour la fabrication d'un medicament destine au traitement du cancer de la prostate
|
|
DE60031279T2
(de)
*
|
1999-07-29 |
2007-05-16 |
Medarex, Inc. |
Humane monoklonale antikörper gegen prostata spezifisches membranantigen
|
|
EP1710256A1
(en)
*
|
1999-07-29 |
2006-10-11 |
Medarex, Inc. |
Human monoclonal antibodies to prostate specific membrane antigen
|
|
EP1221053A4
(en)
*
|
1999-09-13 |
2004-12-22 |
Neil H Bander |
METHOD FOR INSULATING PROSTATIC EPITHELIC CELLS FROM SPERM
|
|
US20080153119A1
(en)
*
|
1999-09-24 |
2008-06-26 |
Schebo Biotech Ag |
Detecting the presence of pyruvate kinase isoenzyme in feces
|
|
EP1263447B1
(en)
|
2000-02-08 |
2013-06-26 |
Rice University |
Optically-active nanoparticles for use in therapeutic and diagnostic methods
|
|
US6379550B1
(en)
*
|
2000-07-24 |
2002-04-30 |
Health Research, Inc. |
Method for detecting PSA and its molecular forms using thiophilic gel
|
|
US7048931B1
(en)
|
2000-11-09 |
2006-05-23 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
|
US7468354B2
(en)
|
2000-12-01 |
2008-12-23 |
Genspera, Inc. |
Tissue specific prodrugs
|
|
WO2002096460A1
(en)
*
|
2001-05-30 |
2002-12-05 |
Cornell Research Foundation, Inc. |
Endopeptidase/anti-psma antibody fusion proteins for treatment of cancer
|
|
US7514078B2
(en)
*
|
2001-06-01 |
2009-04-07 |
Cornell Research Foundation, Inc. |
Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies
|
|
ATE535258T1
(de)
*
|
2001-06-01 |
2011-12-15 |
Cornell Res Foundation Inc |
Modifizierte antikörper gegen prostata- spezifisches membranantigen und ihre verwendungen
|
|
US7666414B2
(en)
*
|
2001-06-01 |
2010-02-23 |
Cornell Research Foundation, Inc. |
Methods for treating prostate cancer using modified antibodies to prostate-specific membrane antigen
|
|
US20060073530A1
(en)
*
|
2001-08-15 |
2006-04-06 |
Olaf Schneewind |
Methods and compositions involving sortase B
|
|
US20050123476A1
(en)
*
|
2001-09-05 |
2005-06-09 |
The Government Of The United States As Represented By The Secretary Of The Department Of Health And |
Imaging the activity of extracellular protease in cells using mutant anthrax toxin protective antigens that are cleaved by specific extracellular proteases
|
|
JP2005527474A
(ja)
*
|
2001-09-20 |
2005-09-15 |
コーネル リサーチ ファンデーション インコーポレーテッド |
前立腺特異的膜抗原に特異的な結合剤を用いて、皮膚障害を治療するかまたは防止するための方法および組成物
|
|
EP1432447A2
(en)
*
|
2001-09-27 |
2004-06-30 |
The Board Of Regents, The University Of Texas System |
Combined compositions and methods for tumor vasculature coagulation and treatment
|
|
ES2559002T3
(es)
*
|
2001-10-23 |
2016-02-10 |
Psma Development Company, L.L.C. |
Anticuerpos contra PSMA
|
|
US20050215472A1
(en)
*
|
2001-10-23 |
2005-09-29 |
Psma Development Company, Llc |
PSMA formulations and uses thereof
|
|
US20040161776A1
(en)
*
|
2001-10-23 |
2004-08-19 |
Maddon Paul J. |
PSMA formulations and uses thereof
|
|
US7591994B2
(en)
|
2002-12-13 |
2009-09-22 |
Immunomedics, Inc. |
Camptothecin-binding moiety conjugates
|
|
US7767803B2
(en)
*
|
2002-06-18 |
2010-08-03 |
Archemix Corp. |
Stabilized aptamers to PSMA and their use as prostate cancer therapeutics
|
|
EP2283868B1
(en)
|
2002-07-15 |
2016-03-30 |
Board of Regents, The University of Texas System |
Peptides binding to phosphatidylethanolamine and their use in treating viral infections and cancer
|
|
US7390898B2
(en)
|
2002-08-02 |
2008-06-24 |
Immunogen Inc. |
Cytotoxic agents containing novel potent taxanes and their therapeutic use
|
|
DE60323677D1
(de)
*
|
2003-01-10 |
2008-10-30 |
Millennium Pharm Inc |
Verfahren zur bestimmung des wiederauftretens von prostata krebs
|
|
US7811564B2
(en)
|
2003-01-28 |
2010-10-12 |
Proscan Rx Pharma |
Prostate cancer diagnosis and treatment
|
|
EP1610818A4
(en)
*
|
2004-03-03 |
2007-09-19 |
Millennium Pharm Inc |
MODIFIED ANTIBODIES AGAINST A PROSTATE-SPECIFIC MEMBRANE-ANTIGEN AND USE THEREOF
|
|
WO2005092286A2
(en)
*
|
2004-03-29 |
2005-10-06 |
The University Of Houston System |
Metallic nano-particles and discrete polymer-coated nano-particles
|
|
US7910693B2
(en)
*
|
2004-04-19 |
2011-03-22 |
Proscan Rx Pharma Inc. |
Prostate cancer diagnosis and treatment
|
|
EP1819277A4
(en)
*
|
2004-11-12 |
2010-05-05 |
Ltd Kpe |
NANOTE PARTICLE-MEDIATED ULTRASOUND THERAPY AND DIAGNOSTIC IMAGE DISPLAY
|
|
WO2006086345A2
(en)
*
|
2005-02-07 |
2006-08-17 |
The Trustees Of Columbia University In The City Of New York |
Methods to treat or prevent hormone-resistant prostate cancer using sirna specific for protocadherin-pc, or other inhibitors of protocadherin-pc expression or activity
|
|
WO2006089230A2
(en)
*
|
2005-02-18 |
2006-08-24 |
Medarex, Inc. |
Human monoclonal antibodies to prostate specific membrane antigen (psma)
|
|
WO2006089231A2
(en)
*
|
2005-02-18 |
2006-08-24 |
Medarex, Inc. |
Monoclonal antibodies against prostate specific membrane antigen (psma) lacking in fucosyl residues
|
|
JP2008536485A
(ja)
*
|
2005-03-07 |
2008-09-11 |
アーケミックス コーポレイション |
Ｐｓｍａに対する安定化したアプタマーおよび前立腺癌治療薬としてのそれらの使用
|
|
EP1726650A1
(en)
|
2005-05-27 |
2006-11-29 |
Universitätsklinikum Freiburg |
Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen
|
|
US7736647B2
(en)
*
|
2005-06-15 |
2010-06-15 |
Monoclonal Antibodies Therapeutics |
Anti-CD71 monoclonal antibodies and uses thereof for treating malignant tumor cells
|
|
BRPI0612529A2
(pt)
*
|
2005-06-20 |
2010-11-23 |
Psma Dev Company Llc |
conjugados de anticorpo-medicamento de psma
|
|
KR20080056167A
(ko)
*
|
2005-09-26 |
2008-06-20 |
메다렉스, 인코포레이티드 |
씨디70에 대한 인간 모노크로날 항체
|
|
MX2008007682A
(es)
*
|
2005-12-20 |
2008-10-23 |
Sbi Biotech Co Ltd |
Anticuerpo anti-ilt7.
|
|
NZ574215A
(en)
*
|
2006-07-18 |
2012-07-27 |
Sanofi Aventis |
Antagonist antibody against epha2 for the treatment of cancer
|
|
JP2010513306A
(ja)
*
|
2006-12-14 |
2010-04-30 |
メダレックス インコーポレーティッド |
Ｃｄ７０に結合するヒト抗体およびその使用
|
|
US20090029408A1
(en)
*
|
2007-07-25 |
2009-01-29 |
Wyeth |
Methods for Characterizing Cell Proximity
|
|
CA2700410C
(en)
|
2007-10-03 |
2020-10-06 |
Cornell University |
Treatment of proliferative disorders using antibodies to psma
|
|
CA2721169A1
(en)
*
|
2008-04-14 |
2009-10-22 |
Proscan Rx Pharma Inc. |
Prostate specific membrane antigen antibodies and antigen binding fragments
|
|
WO2010027513A2
(en)
|
2008-09-08 |
2010-03-11 |
Psma Development Company, Llc |
Methods for killing psma-expressing, taxane-resistant cancer cells
|
|
US20100082438A1
(en)
*
|
2008-10-01 |
2010-04-01 |
Ronnie Jack Garmon |
Methods and systems for customer performance scoring
|
|
MD36Z
(ro)
*
|
2008-12-02 |
2010-01-31 |
Василе ЖОВМИР |
Metodă de tratament diferenţiat al carcinomului ductal in situ neinvaziv al glandei mamare
|
|
MD23Z
(ro)
*
|
2008-12-02 |
2010-01-31 |
Василе ЖОВМИР |
Metodă de tratament diferenţiat al carcinomului lobular in situ neinvaziv al glandei mamare
|
|
MD24Z
(ro)
*
|
2008-12-02 |
2010-01-31 |
Василе ЖОВМИР |
Metodă de tratament diferenţiat al carcinomului neinvaziv al glandei mamare
|
|
MD35Z
(ro)
*
|
2008-12-02 |
2010-01-31 |
Василе ЖОВМИР |
Metodă de apreciere a riscului dezvoltării carcinomului neinvaziv in situ al glandei mamare
|
|
ES2738700T3
(es)
|
2009-02-13 |
2020-01-24 |
Immunomedics Inc |
Inmunoconjugados con un enlace escindible intracelularmente
|
|
WO2010096486A1
(en)
|
2009-02-17 |
2010-08-26 |
Cornell Research Foundation, Inc. |
Methods and kits for diagnosis of cancer and prediction of therapeutic value
|
|
US20120183847A1
(en)
|
2009-05-19 |
2012-07-19 |
Aic Blab |
Composite current collector and methods therefor
|
|
US8221753B2
(en)
|
2009-09-30 |
2012-07-17 |
Tracon Pharmaceuticals, Inc. |
Endoglin antibodies
|
|
CA2782194C
(en)
|
2009-12-02 |
2018-01-16 |
Immunomedics, Inc. |
Combination of radiolabelled antibodies (rait) and antibody-drug conjugates (adc) for treatment of pancreatic cancer
|
|
EP2506876B1
(en)
|
2009-12-02 |
2016-10-12 |
Imaginab, Inc. |
J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use
|
|
CA2793753C
(en)
|
2010-03-26 |
2018-06-05 |
Memorial Sloan-Kettering Cancer Center |
Antibodies to muc16 and methods of use thereof
|
|
JP5702944B2
(ja)
*
|
2010-03-31 |
2015-04-15 |
独立行政法人国立がん研究センター |
バイオマーカー
|
|
US9133239B2
(en)
|
2010-04-20 |
2015-09-15 |
The Research Foundation For The State University Of New York |
Compositions and methods for inhibiting matrix metalloproteinase (MMP)-mediated cell migration
|
|
KR20130036012A
(ko)
*
|
2010-05-07 |
2013-04-09 |
에프. 호프만-라 로슈 아게 |
생체외 세포의 검출을 위한 진단 방법
|
|
US20120148559A1
(en)
|
2010-12-01 |
2012-06-14 |
Board Of Regents The University Of Texas System |
Compositions and method for deimmunization of proteins
|
|
WO2012106368A2
(en)
|
2011-01-31 |
2012-08-09 |
The Regents Of The University Of California |
Methods for inhibiting prostate cancer
|
|
US8314566B2
(en)
*
|
2011-02-22 |
2012-11-20 |
Quarkstar Llc |
Solid state lamp using light emitting strips
|
|
CN103501825B
(zh)
|
2011-05-02 |
2017-03-15 |
免疫医疗公司 |
用于小体积施用的同种异型选择的抗体的超滤浓缩
|
|
KR102143664B1
(ko)
|
2012-06-07 |
2020-08-11 |
암브룩스, 인코포레이티드 |
전립선 특이적 막 항원 항체 약물 접합체
|
|
CA2876706A1
(en)
|
2012-06-14 |
2013-12-19 |
Ambrx, Inc. |
Anti-psma antibodies conjugated to nuclear receptor ligand polypeptides
|
|
EP2885002A4
(en)
|
2012-08-14 |
2016-04-20 |
Ibc Pharmaceuticals Inc |
BISPECIFIC ANTIBODIES REDIRECTED AGAINST T CELLS FOR THE TREATMENT OF DISEASES
|
|
UA115789C2
(uk)
|
2012-09-05 |
2017-12-26 |
Трейкон Фармасутікалз, Інк. |
Композиція антитіла до cd105 та її застосування
|
|
US20140099257A1
(en)
*
|
2012-10-05 |
2014-04-10 |
Cornell University |
Androgen Suppression, Prostate-Specific Membrane Antigen and the Concept of Conditionally Enhanced Vulnerability
|
|
KR101645905B1
(ko)
|
2012-10-12 |
2016-08-04 |
스피로즌 살 |
피롤로벤조디아제핀 및 그의 컨주게이트
|
|
AU2013360335B2
(en)
|
2012-12-13 |
2017-12-07 |
Immunomedics, Inc. |
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
|
|
US11242399B2
(en)
|
2013-02-19 |
2022-02-08 |
Adienne S.A. |
Anti-CD26 antibodies
|
|
EP2968585B1
(en)
|
2013-03-13 |
2018-07-18 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
|
KR102218494B1
(ko)
|
2013-03-15 |
2021-02-19 |
인트린식 라이프사이언시스, 엘엘씨 |
항-헵시딘 항체 및 그의 용도
|
|
JP6908964B2
(ja)
|
2013-10-18 |
2021-07-28 |
ピーエスエムエー ディベロップメント カンパニー，エルエルシー |
Ｐｓｍａリガンドコンジュゲートによる併用療法
|
|
US20150147339A1
(en)
|
2013-11-15 |
2015-05-28 |
Psma Development Company, Llc |
Biomarkers for psma targeted therapy for prostate cancer
|
|
EP3107577B1
(en)
|
2014-02-21 |
2024-03-20 |
IBC Pharmaceuticals, Inc. |
Disease therapy by inducing immune response to trop-2 expressing cells
|
|
CN106029098A
(zh)
|
2014-02-25 |
2016-10-12 |
免疫医疗公司 |
人源化rfb4抗cd22抗体
|
|
HUE056023T2
(hu)
|
2014-05-22 |
2022-01-28 |
Byondis Bv |
Kapcsolt drogok helyspecifikus konjugációja ellenanyagokhoz, és a kapott ADC-k
|
|
WO2015200260A1
(en)
|
2014-06-24 |
2015-12-30 |
Immunomedics, Inc. |
Anti-histone therapy for vascular necrosis in severe glomerulonephritis
|
|
WO2016037644A1
(en)
|
2014-09-10 |
2016-03-17 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
|
AU2015321462B2
(en)
|
2014-09-22 |
2020-04-30 |
Intrinsic Lifesciences Llc |
Humanized anti-hepcidin antibodies and uses thereof
|
|
CA2961774C
(en)
|
2014-10-07 |
2023-05-23 |
Immunomedics, Inc. |
Neoadjuvant use of antibody-drug conjugates
|
|
US9926375B2
(en)
|
2014-11-12 |
2018-03-27 |
Tracon Pharmaceuticals, Inc. |
Anti-endoglin antibodies and uses thereof
|
|
WO2016077451A1
(en)
|
2014-11-12 |
2016-05-19 |
Tracon Pharmaceuticals, Inc. |
Anti-endoglin antibodies and uses thereof
|
|
CN104447955B
(zh)
*
|
2014-11-23 |
2018-04-20 |
南京市第一医院 |
一种与psma膜外区靶向性结合的多肽及其应用
|
|
EP3064507A1
(en)
|
2015-03-06 |
2016-09-07 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Fusion proteins comprising a binding protein and an interleukin-15 polypeptide having a reduced affinity for IL15ra and therapeutic uses thereof
|
|
WO2016149485A1
(en)
|
2015-03-17 |
2016-09-22 |
The Regents Of The University Of California |
Novel chemoimmunotherapy for epithelial cancer
|
|
EP4190817A1
(en)
|
2015-03-17 |
2023-06-07 |
Memorial Sloan Kettering Cancer Center |
Anti-muc16 antibodies and uses thereof
|
|
US9797907B2
(en)
|
2015-04-22 |
2017-10-24 |
Immunomedics, Inc. |
Isolation, detection, diagnosis and/or characterization of circulating Trop-2-positive cancer cells
|
|
ES2889906T3
(es)
|
2015-05-21 |
2022-01-14 |
Harpoon Therapeutics Inc |
Proteínas de unión triespecíficas y usos médicos
|
|
JP6980980B2
(ja)
|
2015-06-25 |
2021-12-15 |
イミューノメディクス、インコーポレイテッドImmunomedics, Inc. |
抗ｈｌａ‐ｄｒまたは抗ｔｒｏｐ‐２抗体と微小管阻害剤、ｐａｒｐ阻害剤、ブルトンキナーゼ阻害剤またはホスホイノシチド３‐キナーゼ阻害剤との併用は癌の治療効果を有意に改善する
|
|
EP3316885B1
(en)
|
2015-07-01 |
2021-06-23 |
Immunomedics, Inc. |
Antibody-sn-38 immunoconjugates with a cl2a linker
|
|
JOP20160154B1
(ar)
|
2015-07-31 |
2021-08-17 |
Regeneron Pharma |
أجسام ضادة مضاد لل psma، وجزيئات رابطة لمستضد ثنائي النوعية الذي يربط psma و cd3، واستخداماتها
|
|
WO2017027325A1
(en)
|
2015-08-07 |
2017-02-16 |
Imaginab, Inc. |
Antigen binding constructs to target molecules
|
|
EP3192810A1
(en)
*
|
2016-01-14 |
2017-07-19 |
Deutsches Krebsforschungszentrum |
Psma binding antibody and uses thereof
|
|
US11623958B2
(en)
|
2016-05-20 |
2023-04-11 |
Harpoon Therapeutics, Inc. |
Single chain variable fragment CD3 binding proteins
|
|
CA3024723A1
(en)
|
2016-05-20 |
2017-11-23 |
Robert B. Dubridge |
Single domain serum albumin binding protein
|
|
PT3461261T
(pt)
|
2016-05-20 |
2025-07-31 |
Harpoon Therapeutics Inc |
Proteínas de ligação ao cd3 de fragmento variável de cadeia única
|
|
US11485792B2
(en)
|
2016-06-06 |
2022-11-01 |
Polytherics Limited |
Antibodies, uses thereof and conjugates thereof
|
|
GB201614162D0
(en)
|
2016-08-18 |
2016-10-05 |
Polytherics Ltd |
Antibodies, uses thereof and conjugates thereof
|
|
JP2019534882A
(ja)
|
2016-10-11 |
2019-12-05 |
メドイミューン・リミテッドＭｅｄＩｍｍｕｎｅ Ｌｉｍｉｔｅｄ |
免疫介在性療法薬を有する抗体−薬物コンジュゲート
|
|
KR20190087539A
(ko)
|
2016-11-23 |
2019-07-24 |
하푼 테라퓨틱스, 인크. |
Psma 표적화 삼중특이성 단백질 및 사용 방법
|
|
EP3544997A4
(en)
|
2016-11-23 |
2020-07-01 |
Harpoon Therapeutics, Inc. |
PROSTATE SPECIFIC MEMBRANE ANTIGEN BINDING PROTEIN
|
|
US11266745B2
(en)
|
2017-02-08 |
2022-03-08 |
Imaginab, Inc. |
Extension sequences for diabodies
|
|
US11535668B2
(en)
|
2017-02-28 |
2022-12-27 |
Harpoon Therapeutics, Inc. |
Inducible monovalent antigen binding protein
|
|
CN115028727A
(zh)
|
2017-05-12 |
2022-09-09 |
哈普恩治疗公司 |
靶向msln的三特异性蛋白质及使用方法
|
|
BR112019023855B1
(pt)
|
2017-05-12 |
2021-11-30 |
Harpoon Therapeutics, Inc |
Proteínas de ligação à mesotelina
|
|
IL315737A
(en)
|
2017-10-13 |
2024-11-01 |
Harpoon Therapeutics Inc |
B-cell maturation antigen-binding proteins
|
|
JP7084990B2
(ja)
|
2017-10-13 |
2022-06-15 |
ハープーン セラピューティクス，インク． |
三重特異性タンパク質と使用方法
|
|
CN111511484A
(zh)
|
2017-11-04 |
2020-08-07 |
索纳纳米技术公司 |
金属纳米颗粒及制备所述金属纳米颗粒的方法
|
|
CN112119157B
(zh)
|
2018-03-06 |
2025-01-14 |
宾夕法尼亚大学董事会 |
前列腺特异性膜抗原car及其使用方法
|
|
US12059473B2
(en)
*
|
2018-03-29 |
2024-08-13 |
Ambrx, Inc. |
Humanized anti-prostate -specific membrane antigen (PSMA) antibody drug conjugates
|
|
WO2019222283A1
(en)
|
2018-05-14 |
2019-11-21 |
Harpoon Therapeutics, Inc. |
Binding moiety for conditional activation of immunoglobulin molecules
|
|
JP2021524449A
(ja)
|
2018-05-23 |
2021-09-13 |
アーデーセー セラピューティクス ソシエテ アノニム |
分子アジュバント
|
|
EP3587454A1
(en)
*
|
2018-06-27 |
2020-01-01 |
Albert-Ludwigs-Universität Freiburg |
Chimeric antigen receptors that bind to prostate specific membrane antigen
|
|
HUE061078T2
(hu)
|
2018-07-31 |
2023-05-28 |
Heidelberg Pharma Res Gmbh |
PSMA elleni humanizált ellenanyagok
|
|
US12195544B2
(en)
|
2018-09-21 |
2025-01-14 |
Harpoon Therapeutics, Inc. |
EGFR binding proteins and methods of use
|
|
CN113286817B
(zh)
|
2018-09-25 |
2025-01-28 |
哈普恩治疗公司 |
Dll3结合蛋白及使用方法
|
|
AU2020223031B2
(en)
|
2019-02-12 |
2024-08-29 |
Ambrx, Inc. |
Compositions containing, methods and uses of antibody-TLR agonist conjugates
|
|
USD925928S1
(en)
|
2019-03-01 |
2021-07-27 |
Simplehuman, Llc |
Vanity mirror
|
|
US12516128B2
(en)
|
2019-05-14 |
2026-01-06 |
Harpoon Therapeutics, Inc. |
EpCAM binding proteins and methods of use
|
|
IL295448A
(en)
|
2020-02-21 |
2022-10-01 |
Harpoon Therapeutics Inc |
flt3 binding proteins and methods of use
|
|
EP4178624A2
(en)
|
2020-07-07 |
2023-05-17 |
Bionecure Therapeutics, Inc. |
Maytansinoids as adc payloads and their use for the treatment of cancer
|
|
US20230372528A1
(en)
|
2020-10-16 |
2023-11-23 |
University Of Georgia Research Foundation, Inc. |
Glycoconjugates
|
|
CN112285082A
(zh)
*
|
2020-10-28 |
2021-01-29 |
上海睿钰生物科技有限公司 |
一种基于细胞直径评价细胞杀伤效力的方法及其应用
|
|
GB202102396D0
(en)
|
2021-02-19 |
2021-04-07 |
Adc Therapeutics Sa |
Molecular adjuvant
|
|
JPWO2022239720A1
(enExample)
|
2021-05-10 |
2022-11-17 |
|
|
|
WO2022078524A2
(en)
|
2021-11-03 |
2022-04-21 |
Hangzhou Dac Biotech Co., Ltd. |
Specific conjugation of an antibody
|
|
JP2026507228A
(ja)
|
2023-03-03 |
2026-02-27 |
アーセナル バイオサイエンシズ インコーポレイテッド |
Ｐｓｍａ及びｃａ９を標的とするシステム
|